Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Uterine Cervical Neoplasms 3Esophageal Neoplasms 3Lymphatic Metastasis 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Recurrence 1Pathologic Complete Response 1Neoplasm Metastasis 1Melanoma 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Carboplatin 84Cisplatin 80Pemetrexed 72Docetaxel 60Gemcitabine 43Drug Therapy 43Erlotinib Hydrochloride 42Gefitinib 38Radiotherapy 36Paclitaxel 36pembrolizumab 31Bevacizumab 29icotinib 28osimertinib 27anlotinib 26Nivolumab 24camrelizumab 23Vinorelbine 23Radiosurgery 20aumolertinib 18atezolizumab 17sintilimab 16apatinib 16Endostatins 16endostar protein 15durvalumab 13Surgical Procedures, Operative 13Immunotherapy 12Immune Checkpoint Inhibitors 12Blood Specimen Collection 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Non-Small-Cell Lung × TP protocol × Clear all
NCT01393080 2016-02-17

NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
160 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01902875 2013-07-18

Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy

Jinling Hospital, China

Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡